Perspective Therapeutics, Inc (CATX) insider trading

Every open-market stock purchase and sale by Perspective Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • No open-market insider trades in the last 12 months.
  • Last insider buy: Jonathan Robert Hunt (C-suite exec), $22.3K, 11 months ago.

Last 12 months: insiders bought $42.2K (2 buys) and sold $0 (0 sales). Last close $3.03 on Jun 4, 2026.

Recent CATX insider trades

DateInsiderTradeValue
Mar 2, 2026Frank Morich (Insider)Bought (not open market)—
Mar 2, 2026Maria E Martinez (Insider)Bought (not open market)—
Mar 2, 2026Markus Puhlmann (C-suite exec)Bought (not open market)—
Mar 2, 2026Heidi Henson (Insider)Bought (not open market)—
Mar 2, 2026Jonathan Robert Hunt (C-suite exec)Bought (not open market)—
Mar 2, 2026Johan M. Spoor (CEO)Bought (not open market)—
Mar 2, 2026Robert F Williamson III (Insider)Bought (not open market)—
Mar 2, 2026Lori A Woods (Insider)Bought (not open market)—
Nov 13, 2025Jonathan Robert Hunt (C-suite exec)Bought$22.3K
Nov 12, 2025Robert F Williamson III (Insider)Bought$19.9K

Who's trading CATX

Get free alerts when an insider at Perspective Therapeutics, Inc files a new trade →